Biden's Spin on Marijuana's Rescheduling Exaggerates Its Practical Impact Contrary to the president's rhetoric, moving marijuana to Schedule III will leave federal pot prohibition essentially unchanged. Reason · May 17, 2024
Did Neuralink Ignore Early Trial Risk? Brain Implant Issues Plagued Lab Before Human Case Neuralink's first brain implant faces thread malfunction, but the patient still plays games & browses the web using thought control. International Business Times UK · May 16, 2024
How To Buy Modafinil Online | Complete Guide For 2024 Widely embraced by top professionals, especially in tech-centric areas like Silicon Valley and beyond, Modafinil has become synonymous with heightened productivity and cognitive enhancement. International Business Times · May 15, 2024
Aldi and Hy-Vee stores recall cream cheese varieties for possible salmonella risk There have been no reports of negative reactions as a result of the recall, the FDA said last week. The products should be thrown away, or returned to either an Aldi or HyVee store for a full refund. WEKU · May 15, 2024
Lots of drug companies talk about putting patients first — but this one actually did When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn't work, the company took the unusual step of voluntarily pulling it off the market. WEKU · May 15, 2024
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them. WEKU · May 13, 2024
FDA Considers New Malaria Test For Blood Banks FDA considers new malaria test for blood donors to prevent transfusion-related cases and enhance safety. Top News · May 12, 2024
Survey Reveals High Demand For GLP-1 Drugs In US Learn about the prevalence and usage of GLP-1 drugs like Ozempic and Mounjaro in the US, including concerns over affordability and supply shortages. Top News · May 12, 2024
Martinelli’s brand apple juice recalled The arsenic levels found in the apple juice exceeded the guidance action level for arsenic set by the FDA in June Salon · May 10, 2024
Novavax strikes $1.2 billion deal with Sanofi in major turnaround It's a major turnaround for a drug company that warned last year about its ability to stay in business. Axios · May 10, 2024
First UK deportation flight to Rwanda could take off in June, court papers suggest Government sources had indicated flights would begin in July, but order shows first could happen on 24 June The Guardian - UK · May 10, 2024
Bird flu FAQ: Everything you need to know about the H5N1 outbreak that’s spread to dairy cows in 9 states The disease has spread to poultry in 48 states, dairy cattle in nine, and two people in Texas and Colorado. Fortune · May 10, 2024
Trial will link senior civil servants’ pay to performance, says UK minister Move intended to boost standards and attract recruits from private sector criticised as ‘tinkering’ by FDA union The Guardian - UK · May 9, 2024
The FDA misses its own deadline to propose a ban on formaldehyde from hair products It is unclear why the suggested rule was not released by its intended deadline. But a spokesperson for the federal agency told NPR that its implementation "continues to be a high priority." WEKU · May 8, 2024
Top News · May 8, 2024 FDA Allows Yogurt Claim For Reducing Type 2 Diabetes Risk Discover how incorporating yogurt into your diet can help reduce the risk of type 2 diabetes, as approved by the FDA.
Top News · May 7, 2024 FDA Allows Yogurt Claim To Reduce Diabetes Risk FDA allows yogurt producers to claim reduced Type 2 diabetes risk despite limited evidence. Consumers advised to critically evaluate labeling claims.
Android Central · May 6, 2024 Samsung wants to convert your Galaxy Watch heart data into ECGs using GenAI Samsung already has passive AFib detection of irregular heart rhythm. This new patent will use generative AI to convert PPG data into ECG graphs — and we're intrigued.
Salon · May 3, 2024 Coach's death due to chemo drug shortage "There's not enough profit" for drug-makers in life-saving cancer meds, and the FDA can't force them
StockNews.com · May 3, 2024 Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings? Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.
StockNews.com · May 3, 2024 3 Pharma Stocks to Snatch up During Market Dips The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more.
Tom’s Guide · May 3, 2024 The Apple Watch just made history with a feature that can save your life The FDA has just approved the Apple Watch's AFib feature in a watershed moment for digital health tech.
TechRadar · May 3, 2024 A key Apple Watch health feature just got a landmark stamp of approval Regulators in the US say the atrial fibrillation history feature can be used to assess other devices.
Al Jazeera · May 2, 2024 What is behind the insulin shortage in the US? Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.
StockNews.com · May 2, 2024 Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…
Bangkok Post · May 2, 2024 Dept issues warning on kratom drinks The Department of Medical Sciences has warned against overconsumption of kratom-mixed beverages, saying the drink may contain a higher level of mitragynine than the Food and Drug Administration's (FDA) recommendation.